@article {Jayaraman2021.02.25.21252488, author = {Bagavad Gita Jayaraman and Gunaseelan Rajan and Priya Kannian and Chandra Lavanya and Krittika Ravichandran and Nagalingeswaran Kumarasamy and Kannan Ranganathan and Veeraraghavan Aswini and Pasuvaraj Mahanathi and Stephen Challacombe and Jennifer Webster-Cyriaque and Newell W Johnson}, title = {Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets}, elocation-id = {2021.02.25.21252488}, year = {2021}, doi = {10.1101/2021.02.25.21252488}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {SARS-CoV2 is transmitted primarily through oral mouth secretions and respiratory droplets. Commercial mouthwashes, povidone iodine (PI), hydrogen peroxide (HP) and chlorhexidine (CHX) have been tested in cell culture and RT-PCR studies for their efficacy to reduce SARS-CoV2 burden. Here, we evaluated SARS-CoV2 burden in whole mouth fluid (WMF) and respiratory droplets (RD) samples before and after the use of PI, HP or CHX mouthwashes in hospitalized COVID-19 patients using RT-PCR and rapid antigen test (RAT). Thirty-six SARS-CoV2 RT-PCR-positive in-patients were randomly assigned to one of the four groups: 20 and 60 minutes after 1\% w/v PI or 1.5\% HP; 90 and 180 minutes after 1.5\% HP or 0.2\% w/v CHX. WMF and RD samples were collected concurrently at baseline and after the two different time points. RD (92\%) showed a higher reduction in SARS-CoV2 burden than WMF samples (50\%; p=0.008). SARS-CoV2 burden was statistically lower at both 20 minutes (p=0.02) and 60 minutes (p=0.03) with PI; at 20 minutes with HP (p=0.0001); and 90 minutes with CHX (p=0.04). The overall and individual mean logarithmic reductions in the WMF and RD samples were greater than 1.0 at 20, 60 and 90 minutes after PI, HP or CHX. RAT-positive patients at 90 minutes post-treatment (n=3) demonstrated a one log increase in virus copies. Among the three RAT-negative post-treatment patients, SARS-CoV2 burden declined by one log in two while the third patient had a slight increase in RNA copies. In conclusion, we have shown for the first time that the mouthwashes, PI, HP and CHX can reduce the SARS-CoV2 burden in the concurrently collected RD and WMF samples. RAT is more appropriate than RT-PCR to evaluate the efficacy of the mouthwashes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the intramural funds of Chennai Dental Research Foundation, Chennai, India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by VHS-Institutional Ethics Committee (VHS-IEC/60-2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is not available in the links.}, URL = {https://www.medrxiv.org/content/early/2021/03/01/2021.02.25.21252488}, eprint = {https://www.medrxiv.org/content/early/2021/03/01/2021.02.25.21252488.full.pdf}, journal = {medRxiv} }